While many aspects related to the pathobiology of L1CAM in the tumor vascular bed remain to be explored, this Ig-CAM may provide novel and alternative strategies in the context of vascular-targeting therapies in neoplastic diseases. This evidence concerns the gene L1CAM and neoplasm.